Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Novavax, Inc.    NVAX

NOVAVAX, INC.

(NVAX)
  Report
Delayed Quote. Delayed Nasdaq - 11/25 04:00:01 pm
102.6 USD   +7.63%
04:16pNOVAVAX : to Participate in Upcoming Conferences
AQ
04:15pNovavax to Participate in Upcoming Conferences
GL
01:52pHow will Canada's COVID-19 vaccine program work?
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Novavax : U.S. dollar gains on surge in COVID-19 cases, lockdowns in Europe

10/28/2020 | 02:17pm EST
Illustration photo of U.S. Dollar and Euro notes

NEW YORK (Reuters) - The safe-haven dollar rose on Wednesday, pushing the euro to one-week lows, on news of lockdowns in Germany and France as coronavirus cases surged, with implied volatility gauges in the European currency and the yen hitting multi-month highs as traders positioned for next Tuesday's U.S. election.

Germany decided to shut bars and restaurants for a month and France prepared to tighten controls on movement as the pandemic surged across Europe and financial markets tumbled at the likely cost of a second lockdown.

The European Commission proposed a series of new measures to fight the pandemic in the European Union, calling the new spike in infections "alarming".

"When things get scary everybody rushes to the dollar," said John Payne, senior futures and options broker, at Daniels Trading, in Chicago.

"The currency markets right now are dealing with problems in Europe, and Europe - I don't know if the market thinks they have a lot of bullets left to fire at this thing. From a quantitative easing standpoint, that's what is going to come. You see the dollar being more attractive because maybe Trump won't go in that direction."

Traders were bracing for volatility as the U.S. election loomed.

Democratic presidential candidate Joe Biden leads Republican President Donald Trump nationally by 10 percentage points, a Reuters/Ipsos poll showed.

"We are seeing some position-trimming ahead of the election, with the market still short dollars," said Vassili Serebriakov, FX strategist at UBS in New York.

"The expectation is for a Biden presidency and that is consistent with a weaker dollar story. But as some of the polls have tightened the last couple of days, markets are just taking some risk off the table given the uncertainty," he added.

The UBS strategist said a Biden administration is seen de-escalating trade tensions with traditional allies such as Europe and Canada, as well as China, which should improve market sentiment overall and weigh on the dollar as a safe haven.

In afternoon trading, the euro <EUR=EBS> was down 0.4% against the dollar at $1.1754, after sliding to a one-week low.

One-month euro/dollar risk reversals <EUR1MRR=FN>, a gauge of currency sentiment in the options market that measures the ratio of calls over puts, showed on Wednesday that investors were most bearish on the European common currency since June.

The dollar though slipped 0.1% against the yen to 104.31 yen <JPY=EBS>. Earlier, the greenback dropped to a more than one-month low.

The euro also fell 0.5% against yen to 122.60 yen, after earlier sinking to its weakest since July.

One-week implied volatility gauges in euro and yen rose to their highest in nearly seven months. <EUR1WO=R> <JPY1WO=R>

That suggests investors are preparing for sharp price moves, focused on both the European lockdowns and the United States as it struggles to contain its coronavirus epidemic ahead of the pivotal election next Tuesday.

Legal battles between Republicans and Democrats over how to count votes have raised the risk that the outcome of the election will be disputed.

The dollar index <=USD>, which tracks the greenback against a basket of six currencies, was up 0.3% at 93.39.

Elsewhere, sterling fell 0.5% versus the dollar to $1.2958 <GBP=D3>.

(Reporting by Gertrude Chavez-Dreyfuss; Additional reporting by Herb Lash; Editing by Jonathan Oatis and David Gregorio)

By Gertrude Chavez-Dreyfuss


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
NOVAVAX, INC. 7.63% 102.6 Delayed Quote.2,295.23%
All news about NOVAVAX, INC.
04:16pNOVAVAX : to Participate in Upcoming Conferences
AQ
04:15pNovavax to Participate in Upcoming Conferences
GL
01:52pHow will Canada's COVID-19 vaccine program work?
RE
06:06aEXPLAINER : When and how will COVID-19 vaccines become available?
RE
11/20Pfizer, BioNTech Ask FDA to Authorize Their Covid-19 Vaccine -- 2nd Update
DJ
11/20Pfizer, BioNTech Ask FDA to Authorize Their Covid-19 Vaccine -- 2nd Update
DJ
11/20Pfizer, BioNTech to Seek Authorization of Covid-19 Vaccine Friday -- Update
DJ
11/20Pfizer to Seek Authorization of Covid-19 Vaccine Friday
DJ
11/18PFIZER, MODERNA COVID-19 VACCINES MA : U.S. official
RE
11/18Pfizer Says Covid Vaccine Is 95% Effective in Final Data, Will Seek Authoriza..
DJ
More news
Financials (USD)
Sales 2020 550 M - -
Net income 2020 -310 M - -
Net cash 2020 465 M - -
P/E ratio 2020 -19,0x
Yield 2020 -
Capitalization 5 247 M 5 247 M -
EV / Sales 2020 8,69x
EV / Sales 2021 1,44x
Nbr of Employees 522
Free-Float 97,6%
Chart NOVAVAX, INC.
Duration : Period :
Novavax, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVAVAX, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 186,20 $
Last Close Price 102,60 $
Spread / Highest target 117%
Spread / Average Target 81,5%
Spread / Lowest Target -26,9%
EPS Revisions
Managers
NameTitle
Stanley C. Erck President, Chief Executive Officer & Director
James F. Young Chairman
Gregory F. Covino Chief Financial Officer & Executive Vice President
Gregory M. Glenn President-Research & Development
Biegie Lee Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NOVAVAX, INC.2,295.23%4 875
LONZA GROUP AG56.17%44 950
MODERNA, INC.403.89%39 001
CELLTRION, INC.82.32%36 284
IQVIA HOLDINGS INC.11.32%32 977
SEAGEN INC.44.80%29 684